Literature DB >> 15710406

1.15 A crystal structure of the X. tropicalis Spred1 EVH1 domain suggests a fourth distinct peptide-binding mechanism within the EVH1 family.

Nicholas J Harmer1, Jeremy M Sivak, Enrique Amaya, Tom L Blundell.   

Abstract

The recently described Spred protein family has been implicated in the modulation of receptor tyrosine kinase signalling. We report the crystal structure of the Enabled/vasodilator-stimulated phosphoprotein homology-1 (EVH1) domain from Xenopus tropicalis Spred1, solved to 1.15 A resolution. This structure confirms that the Spred EVH1 adopts the pleckstrin-homology fold, with a similar secondary structure to Enabled. A translation of one of the peptide-binding groove beta-strands narrows this groove, whilst one end of the groove shows structural flexibility. We propose that Spred1 will bind peptides that are less proline-rich than other EVH1 domains, with conformational changes indicating an induced fit.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710406     DOI: 10.1016/j.febslet.2004.11.114

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Ramachandran analysis of conserved glycyl residues in homologous proteins of known structure.

Authors:  Balasubramanian Lakshmi; Chandrasekaran Sinduja; Govind Archunan; Narayanaswamy Srinivasan
Journal:  Protein Sci       Date:  2014-04-22       Impact factor: 6.725

2.  A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1.

Authors:  Irma B Stowe; Ellen L Mercado; Timothy R Stowe; Erika L Bell; Juan A Oses-Prieto; Hilda Hernández; Alma L Burlingame; Frank McCormick
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

3.  Miniature protein ligands for EVH1 domains: interplay between affinity, specificity, and cell motility.

Authors:  Jennifer H Holtzman; Kamil Woronowicz; Dasantila Golemi-Kotra; Alanna Schepartz
Journal:  Biochemistry       Date:  2007-11-01       Impact factor: 3.162

4.  Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.

Authors:  Yasuko Hirata; Hilde Brems; Mayu Suzuki; Mitsuhiro Kanamori; Masahiro Okada; Rimpei Morita; Isabel Llano-Rivas; Toyoyuki Ose; Ludwine Messiaen; Eric Legius; Akihiko Yoshimura
Journal:  J Biol Chem       Date:  2015-12-03       Impact factor: 5.157

5.  The neurofibromin recruitment factor Spred1 binds to the GAP related domain without affecting Ras inactivation.

Authors:  Theresia Dunzendorfer-Matt; Ellen L Mercado; Karl Maly; Frank McCormick; Klaus Scheffzek
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-16       Impact factor: 11.205

6.  Centromeric binding and activity of Protein Phosphatase 4.

Authors:  Zoltan Lipinszki; Stephane Lefevre; Matthew S Savoian; Martin R Singleton; David M Glover; Marcin R Przewloka
Journal:  Nat Commun       Date:  2015-01-06       Impact factor: 14.919

7.  NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.

Authors:  Sebastian Führer; Linda Ahammer; Angela Ausserbichler; Klaus Scheffzek; Theresia Dunzendorfer-Matt; Martin Tollinger
Journal:  Biomol NMR Assign       Date:  2017-08-22       Impact factor: 0.746

Review 8.  SPRED proteins and their roles in signal transduction, development, and malignancy.

Authors:  Claire Lorenzo; Frank McCormick
Journal:  Genes Dev       Date:  2020-11-01       Impact factor: 11.361

9.  Spred2 interaction with the late endosomal protein NBR1 down-regulates fibroblast growth factor receptor signaling.

Authors:  Faraz K Mardakheh; Mona Yekezare; Laura M Machesky; John K Heath
Journal:  J Cell Biol       Date:  2009-10-12       Impact factor: 10.539

Review 10.  Diversity of polyproline recognition by EVH1 domains.

Authors:  Francis C Peterson; Brian F Volkman
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.